Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Human urothelial bladder cancer generates a clonal immune response: The results of T-cell receptor sequencing

Sankin et al.

  • Urologic Oncology
  • May 2019

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Voorwerk et al.

  • Nature Medicine
  • May 2019

Rational design of anti-GITR-based combination immunotherapy

Zappasodi et al.

  • Nature Medicine
  • April 2019

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

Yang et al.

  • Nature Medicine
  • April 2019

A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL-2-Receptor Beta/Gamma (βγ)-Biased Cytokine, in Patients With Advanced or Metastatic Solid Tumors

Bentebibel et al.

  • Cancer Discovery
  • April 2019

Mobilization of CD8þ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

Seo et al.

  • Clinical Cancer Research
  • April 2019

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

Agdashian et al.

  • Cancer Immunology and Immunotherapy
  • April 2019

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

Sawant et al.

  • Nature Immunology
  • April 2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Cloughesy et al.

  • Nature Medicine
  • March 2019